Citigroup »

Tourmaline Bio shares owned by Citigroup

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by Citigroup

Quarter filed Position value Share count Share price at filing
2024-09-30 $444k 17k 25.71
2024-06-30 $74k 5.7k 12.86
2024-03-31 $202k 8.8k 22.88
2023-12-31 $1.1M 43k 26.13